A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)
A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation
Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome
Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Psychological Concomitants of Morquio A Syndrome – Longitudinal Effects of Enzyme Replacement Therapy (The MAPLE Study)
Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
You're leaving the BioMarin Clinical Trials website.
This will take you to BioMarin.com, our global corporate website. Some of the information on BioMarin.com is intended for U.S. audiences only.
Leave this website
Close
You’re leaving the BioMarin Clinical Trials website.
Links to sites outside of this website are provided as a resource to the viewer. BioMarin accepts no responsibility for the content of linked sites.
Leave this website
Close